Your browser doesn't support javascript.
loading
Risk assessment of post-discharge mortality among recently hospitalized Medicare heart failure patients with reduced or preserved ejection fraction.
Stampehl, Mark; Friedman, Howard S; Navaratnam, Prakash; Russo, Patricia; Park, Siyeon; Obi, Engels N.
Afiliação
  • Stampehl M; Missouri Heart Center, Columbia, MO, USA.
  • Friedman HS; DataMed Solutions LLC, New York, NY, USA.
  • Navaratnam P; DataMed Solutions LLC, New York, NY, USA.
  • Russo P; Novartis Pharmaceutical Corporation, Hanover, NJ, USA.
  • Park S; Pharmacy, University of Maryland, Baltimore, MD, USA.
  • Obi EN; Novartis Pharmaceutical Corporation, Hanover, NJ, USA.
Curr Med Res Opin ; 36(2): 179-188, 2020 02.
Article em En | MEDLINE | ID: mdl-31469001
ABSTRACT

Objective:

Targeted care management for hospitalized patients with acute decompensated heart failure (ADHF) with reduced or preserved ejection fraction (HFrEF/HFpEF) who are at higher risk for post-discharge mortality may mitigate this outcome. However, identification of the most appropriate population for intervention has been challenging. This study developed predictive models to assess risk of 30 day and 1 year post-discharge all-cause mortality among Medicare patients with HFrEF or HFpEF recently hospitalized with ADHF.

Methods:

A retrospective study was conducted using the 100% Centers for Medicare Services fee-for-service sample with complementary Part D files. Eligible patients had an ADHF-related hospitalization and ICD-9-CM diagnosis code for systolic or diastolic heart failure between 1 January 2010 and 31 December 2014. Data partitioned into training (60%), validation (20%) and test sets (20%) were used to evaluate the three model approaches classification and regression tree, full logistic regression, and stepwise logistic regression. Performance across models was assessed by comparing the receiver operating characteristic (ROC), cumulative lift, misclassification rate, the number of input variables and the order of selection/variable importance.

Results:

In the HFrEF (N = 83,000) and HFpEF (N = 123,644) cohorts, 30 day all-cause mortality rates were 6.6% and 5.5%, respectively, and 1 year all-cause mortality rates were 33.6% and 29.5%. The stepwise logistic regression models performed best across both cohorts, having good discrimination (test set ROC of 0.75 for both 30 day mortality models and 0.74 for both 1 year mortality models) and the lowest number of input variables (18-34 variables).

Conclusions:

Post-discharge mortality risk models for recently hospitalized Medicare patients with HFrEF or HFpEF were developed and found to have good predictive ability with ROCs of greater than or equal to 0.74 and a reasonable number of input variables. Applying this risk model may help providers and health systems identify hospitalized Medicare patients with HFrEF or HFpEF who may benefit from more targeted care management.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Volume Sistólico / Medicare / Medição de Risco / Insuficiência Cardíaca Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male País como assunto: America do norte Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Volume Sistólico / Medicare / Medição de Risco / Insuficiência Cardíaca Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male País como assunto: America do norte Idioma: En Ano de publicação: 2020 Tipo de documento: Article